期刊
JOURNAL OF ENDOCRINOLOGY
卷 206, 期 2, 页码 141-157出版社
BIOSCIENTIFICA LTD
DOI: 10.1677/JOE-10-0072
关键词
-
资金
- MRC Human Reproductive Sciences Unit [U.1276.00.004.00002.01, U1276.00.002.00005.01]
- MRC [MC_U127685844, MC_U127684438] Funding Source: UKRI
- Medical Research Council [MC_U127685844, MC_U127684438] Funding Source: researchfish
Endometrial adenocarcinoma is the most common gynaecological malignancy in western countries. Many of the established risk factors for developing endometrial cancer are associated with excess exposure to oestrogen unopposed by progesterone. These include nulliparity, late onset of the menopause, post-menopausal hormone replacement therapy and obesity. However, a number of risk factors also promote inflammation, another feature proposed to influence cancer development. The human cycling endometrium undergoes regular and cyclical episodes of inflammation. Moreover, hormonal and genetic changes that occur early in the development of endometrial adenocarcinoma can exacerbate the local inflammatory environment. Via alterations in the expression of local mediators and immune cell function, these may contribute to the development of endometrial cancer. This review discusses the contribution of inflammation to the initiation and progression of endometrial adenocarcinoma. Manipulation of inflammatory pathways may therefore represent a therapeutic target in endometrial adenocarcinoma. Journal of Endocrinology (2010) 206, 141-157
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据